Literature DB >> 16769761

Splenic endothelial cell lines support development of dendritic cells from bone marrow.

Geneviève Despars1, Helen C O'Neill.   

Abstract

Although growth factors are commonly used to generate dendritic cells (DCs) in vitro, the role of the microenvironment necessary for DC development is still poorly understood. The mixed splenic stromal cell population STX3 defines an in vitro microenvironment supportive of DC development. Dissection of cellular components of the STX3 stroma should provide information about a niche for DC development. STX3 was therefore cloned by single-cell sorting, and a panel of 102 splenic stromal cell lines was established. Four representative splenic stromal cell lines that support hematopoiesis from bone marrow are described here in terms of stromal cell type and DC production. All four stromal lines express the endothelial genes Acvrl1, Cd34, Col18a1, Eng, Flt1, Mcam, and Vcam1 but not Cd31 or Vwf. Three of the four lines form tube-like structures when cultured on Matrigel. Their endothelial maturity correlates with the ability to support myeloid DC development from bone marrow. A fourth cell line, unable to form tube-like structures in Matrigel, produced large granulocytic cells expressing CD11b and CD86 but not CD11c and CD80. Conditioned media from splenic stromal cell lines also support DC production, indicating that soluble growth factors and cytokines produced by stromal lines drive DC development. This article reports characterization of immature endothelial cell lines derived from spleen that are supportive of DC development and predicts the existence of such a cell type in vivo which regulates DC development within spleen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769761     DOI: 10.1634/stemcells.2005-0530

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

1.  Extramedullary hematopoiesis: mesenchymal stromal cells from spleen provide an in vitro niche for myelopoiesis.

Authors:  Sawang Petvises; Vinson Tran; Ying-Ying Hey; Dipti Talaulikar; Terence J O'Neill; Jonathan Tan; Helen C O'Neill
Journal:  In Vitro Cell Dev Biol Anim       Date:  2022-05-31       Impact factor: 2.723

2.  Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib.

Authors:  E Weisberg; A K Azab; P W Manley; A L Kung; A L Christie; R Bronson; I M Ghobrial; J D Griffin
Journal:  Leukemia       Date:  2011-12-20       Impact factor: 11.528

3.  Development of two distinct dendritic-like APCs in the context of splenic stroma.

Authors:  Pravin Periasamy; Sawang Petvises; Helen C O'Neill
Journal:  Front Immunol       Date:  2013-03-20       Impact factor: 7.561

4.  Spleen as a site for hematopoiesis of a distinct antigen presenting cell type.

Authors:  Helen C O'Neill; Kristin L Griffiths; Pravin Periasamy; Rebecca A Hinton; Ying-Ying Hey; Sawang Petvises; Jonathan K H Tan
Journal:  Stem Cells Int       Date:  2011-11-15       Impact factor: 5.443

5.  Myelopoiesis in spleen-producing distinct dendritic-like cells.

Authors:  Jonathan K H Tan; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

6.  Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition.

Authors:  Ellen L Weisberg; Martin Sattler; Abdel Kareem Azab; Dirk Eulberg; Anna Kruschinski; Paul W Manley; Richard Stone; James D Griffin
Journal:  Oncotarget       Date:  2017-11-06

7.  Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.

Authors:  Ellen Weisberg; Renee D Wright; Douglas W McMillin; Constantine Mitsiades; Arghya Ray; Rosemary Barrett; Sophia Adamia; Richard Stone; Ilene Galinsky; Andrew L Kung; James D Griffin
Journal:  Mol Cancer Ther       Date:  2008-04-29       Impact factor: 6.261

8.  Characterisation of dendritic cells arising from progenitors endogenous to murine spleen.

Authors:  Sawang Petvises; Helen C O'Neill
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

9.  Haematopoietic stem cells in spleen have distinct differentiative potential for antigen presenting cells.

Authors:  Jonathan K H Tan; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2010-10-03       Impact factor: 5.310

Review 10.  Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function.

Authors:  Ying Y Hey; Helen C O'Neill
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.